Related Experiment Video
Updated: Jun 7, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Chronic Catatonia in an Individual With a De Novo Missense SHANK1 Variant
Paige M Dahlberg1,2, Holly K Harris1, J Lloyd Holder1,2
1Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Abstract:
SHANK1 encodes a scaffolding protein of the SHANK family that includes SHANK1, SHANK2 and SHANK3. All of the SHANK proteins are enriched at the post-synaptic density of excitatory synapses. Here, we present an 11-year-old boy with a history of developmental delays and no family history of psychiatric disorders who developed catatonia. MRI of his brain and spine were negative as was a workup for autoimmune encephalitis. The proband's genetic testing revealed a de novo heterozygous SHANK1 missense variant. Although catatonia has been reported previously in individuals with SHANK3 loss-of-function mutations, this is the first time catatonia has been described in an individual with a SHANK1 variant.

